Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetylpyridinium Chloride Mouthwash for Gingivitis and Plaque
NCT06933368Completed
- Sponsor
- Haleon
- Start
- Apr 2025
- Primary completion
- Aug 2025
- Modality
- Conventional Liposomes, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of cetylpyridinium chloride in gingivitis and dental plaque (2 arms), sponsored by Haleon. Primary endpoint: Overall Number of Bleeding Sites at 12 weeks. Started Apr 2025; status: completed.
02
Drugs
cetylpyridinium chloride
03
Conditions
gingivitisdental plaque
Beyond the preview
Go deeper on NCT06933368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06933368.